Status:
COMPLETED
The Geneva Covid-19 CVD Study
Lead Sponsor:
François MACH
Conditions:
COVID
CVD
Eligibility:
All Genders
18+ years
Brief Summary
In this study, the investigators propose to analyse the clinical data of all patients admitted in Geneva University Hospitals (HUG) or in a care center in Geneva who are diagnosed with COVID-19. CVD b...
Detailed Description
Hypothesis: COVID-19+ hospitalized patients with preexisting CVD or newly onset CVD at time of hospitalization have different clinical outcomes compared to those without CVD and COVID-19+. Objective...
Eligibility Criteria
Inclusion
- Subject is ≥18 years of age.
- Patient diagnosed SARS-CoV-2 positive at time of hospitalization.
- In case of the subject accepting the follow-up at 30 days and 1 year, Signed Patient Informed Consent (PIC) form
Exclusion
- Patients unwilling to provide informed consent for the follow-up.
Key Trial Info
Start Date :
March 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
1927 Patients enrolled
Trial Details
Trial ID
NCT04384029
Start Date
March 24 2020
End Date
July 31 2021
Last Update
October 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospital (HUG)
Geneva, Switzerland, 1211